Literature DB >> 23384748

Oral contraceptives in adolescent women.

Johannes Bitzer1.   

Abstract

Taking into account the biological and psychosocial changes during the transition from childhood to adulthood adolescents would need a contraceptive method which ideally would be very effective, independent of compliance, without major health risks during use and no negative impact on the future health of the adolescent, protective against STI, favorable for bone development, with no or only few side effects and having some preventive and therapeutic potential with respect to frequent health problems of adolescent girls. Combined oral contraceptives (COC) used regularly and consistently have a more than 99% efficacy to prevent a pregnancy. COCs have a very low health risk (almost exclusively thromboembolic disease) which seems to differ marginally with respect to dosage and type of the components. Progestogen only oral contraceptives do not have any major negative health impact. The leading side effect is irregular bleeding which in COC users is mainly during the first 3 months and in progestogen only users during the period of use. Other side effects are reported but their frequency is similar to placebo. COC protect against endometrial and ovarian cancer and they may have beneficial effects on a variety of menstrual complaints and acne, which are frequent problems during adolescence. To be effective COCs have to be taken regularly which is frequently not the case. This diminishes considerably their effectiveness depending on the individual compliance. They do not protect against STI and may even have an inhibitory effect on the use of condoms. For most adolescents the risk benefit profile of oral contraceptives is favorable and makes this method valuable. At the same time the prescription of oral contraceptives for adolescents need to be individualized by taking into account the individual risk/benefit profile. Specialized counseling with a high degree of confidentiality adapted to the knowledge and needs of the individual adolescent is desirable.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23384748     DOI: 10.1016/j.beem.2012.09.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  4 in total

1.  Papillary Thyroid Cancer-Promoting Activities of Combined Oral Contraceptive Components.

Authors:  Mehdi Hedayati; Sadegh Rajabi; Abdolrahim Nikzamir
Journal:  Galen Med J       Date:  2020-05-21

2.  Oral contraceptive use is not related to gender self-concept.

Authors:  Matthew G Nielson; Adriene M Beltz
Journal:  Psychoneuroendocrinology       Date:  2021-05-14       Impact factor: 4.693

3.  Trends in the use of oral contraceptives among adolescents and young women in Spain.

Authors:  Pilar Carrasco-Garrido; Ana López de Andrés; Valentín Hernández-Barrera; Isabel Jiménez-Trujillo; Mercedes Esteban-Peña; Napoleón Pérez-Farinós; Rodrigo Jiménez-García
Journal:  Reprod Health       Date:  2016-09-23       Impact factor: 3.223

4.  Long-Term (7 Years) Follow-Up of Roux-en-Y Gastric Bypass on Obese Adolescent Patients (<18 Years).

Authors:  Ramon Vilallonga; Jacques Himpens; Simon van de Vrande
Journal:  Obes Facts       Date:  2016-04-02       Impact factor: 3.942

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.